Women in Their 40s Still Getting Mammograms
Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
Women in their 40s continue to undergo screening for breast cancer despite recent guidelines that recommended against routine screening for this age group, according to a new study.
In 2009, the U.S. Preventive Services Task Force issued new breast cancer screening guidelines that recommended women ages 50 to 74 have a mammogram every other year, but that women younger than 50 speak with their doctors to determine if screening is right for them.
The new study found no change in the percentage of women undergoing breast cancer screening before and after the recommendations.
In 2011, 47.5 percent of U.S. women ages 40 to 49 said they received a mammogram in the past year, compared to 46.1 percent in 2008.
The findings suggest that the controversy surrounding the new guidelines may have had an impact on their adoption, the researchers said. They also suggest that it's hard to "undo" screening recommendations, a phenomenon also seen in prostate cancer screening.
Follow Rachael Rettner @RachaelRettner. Follow MyHealthNewsDaily @MyHealth_MHND, Facebook & Google+
Get the world’s most fascinating discoveries delivered straight to your inbox.

Rachael is a Live Science contributor, and was a former channel editor and senior writer for Live Science between 2010 and 2022. She has a master's degree in journalism from New York University's Science, Health and Environmental Reporting Program. She also holds a B.S. in molecular biology and an M.S. in biology from the University of California, San Diego. Her work has appeared in Scienceline, The Washington Post and Scientific American.
